GILD - POTENTIAL BOTTOMAfter almost 10 months we got a signal.
Signal of a potential bottom from BOTH of my dBFIs on the DAILY chart
Awaiting confirmation (close above sma14).Signal valid for 2 weeks.
GILD trade ideas
Long Position in GILD After Bullish BounceAbout a week or so ago, I published an idea about GILD hitting some serious support levels going back to mid to late 2014 - 2015. What I thought back then was that if GILD were able to hold on to that support level, even bounce around it without falling below it, I would enter a position in my paper account at that support level, and place my stop below the support line. So, if my stop is triggered, it signals that my thesis was wrong, and perhaps that I should try it on the short side (still working with ways of changing direction on a time to profit even when my hypothesis is wrong.
Anyways, let's look at the trade. I risked 1.0% of my portfolio with a stop loss at $63. I didn't set any profit targets, and I think I'm going to keep not setting profit targets. The reason being is I want to make sure that I am being diligent in moving my stops with the direction of the trend (if I am right), and let the profit take care of itself.
Trying to stay discipled in capital risk management, and I am getting more confident with it.
All the best,
RC
GILD - Where is the bottom?Where is the bottom? I absolutely DO NOT have the answer.
Volume corresponding to GILD price is interesting. I don't often look at 1M, but it does give an interesting perspective.
Short interest is .98%. I'ts been dropping since 2013.
1W:
1M CELG Comparison:
GILD hitting Major Support LineGilead Sciences is a deep value play, along the likes of a Joel Greenblatt "Magic Formula" stock. Around September I expressed a bullish interest in GILD given its fundamentals and its valuation. During that time, GILD traded at $73. Since I expressed a long interest, the stock has done nothing but decline. Looking back on my initial bullish opinion, I didn't take into consideration the charts, let alone even think about TA.
The fundamental research was over, and due to the fundamentals I didn't really think to take a look at the charts. After all, it was my inner Buffett saying, "Hey, this is a great business, don't even worry about the price, since the company is so great, it doesn't matter. Heck, if it goes lower, buy more!" Well, after reflecting on this consensus I realized how foolish it was of me.
If I would've taken the time to look at the charts, I would have realized that at $73, it didn't have much support on that level, with the most recent support level being at $66.51. So, instead of waiting for that support price to hit, I thought it would be a good idea to buy at $73. Not only did that bullish decision reflect in a loss of capital, but it resulted in dead money, money that could've been used in other capital allocations.
Nevertheless, I like GILDs fundamentals so much I had to take a second look as the share price kept falling. Now, at $66.51, GILD is right at the support level from mid 2014. GILD is still in a bearish channel, but since the company is so solid on its balance sheet and has loads of cash, if the bearish channel is broken upward, I will look to get in around the $71 level.
Will keep watching.
All the best,
RC
Gilead head and shoulders pattern. Levels of support if the head and shoulders pattern continues is $68, $53, and $38.
GILD short opportunityGILD recently bounced to its .618 retracement on what is likely a short squeeze via trading algorithms at the open. Enter this puppy short for the next downside wave.
Target should be $65.
Gilead Sciences Inc. A verry good investment.FUNDAMENTAL AND TECHNICAL.
An effective cure for hepatitis have sent
one of the world's most well-run
pharmaceutical company Gilead Sciences
on sale The medication works, patients
become well, and everyone should be happy.
But the problem is that the medication works to well
and patients doesn't need the medication further
after the treatment. and this can harm the revenue
for the company.
THE TECHNICAL
The E-P-S (earnings pr share) is actually pretty
high at 9.94. The P-E(Price Ernings) Ratio is at 6.94
so investors are willing to pay 6,94 Dollar
pr dollar ernings. where the E-P-S is at 9,94
the dividend yield is at 2,97%
therefore
Gilead sciences dividend payout ratio is
= 2,97/(1/6,94)= 20,61 %
So the dividend payout ratio is really high and
we could se an increase in the stock at 20,61%
that is an increase of 14,28 Dollars pr share.
i will be updating this in the comment with more fundamentals.
Gilead could break downward channel and pop up In downward channel - look for it to break on the upside. Low 7 PE and pays dividend.
verifiedinvesting.com
2017 is GILD's year ?70s is the target for the coming couple of weeks any close above 77 confirms the positivity and close below 66 is a stop loss
Buy low sell highGILD is right at a very nice buy low sell high area on the weekly chart. We hit this level and bounced back in 2014
